|
RCL1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.59355999999056E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.220150E-04 |
| Normal-vs-Stage2 |
3.984900E-03 |
| Normal-vs-Stage3 |
2.005600E-04 |
| Normal-vs-Stage4 |
4.04339999999781E-05 |
| Stage1-vs-Stage2 |
4.574000E-01 |
| Stage1-vs-Stage3 |
4.778200E-01 |
| Stage1-vs-Stage4 |
2.724400E-01 |
| Stage2-vs-Stage3 |
8.501000E-01 |
| Stage2-vs-Stage4 |
9.761600E-01 |
| Stage3-vs-Stage4 |
7.668800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.76039999999889E-05 |
| Normal-vs-AfricanAmerican |
9.198200E-02 |
| Normal-vs-Asian |
3.716400E-03 |
| Caucasian-vs-AfricanAmerican |
6.748600E-01 |
| Caucasian-vs-Asian |
9.829000E-01 |
| AfricanAmerican-vs-Asian |
6.981200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.88239999999929E-05 |
| Normal-vs-Female |
3.88980000000094E-05 |
| Male-vs-Female |
5.058400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.206700E-04 |
| Normal-vs-Age(41-60Yrs) |
3.367000E-04 |
| Normal-vs-Age(61-80Yrs) |
4.462599999977E-06 |
| Normal-vs-Age(81-100Yrs) |
6.783000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.871800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.971850E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.379800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.651600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.359400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.713400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.896600E-01 |
| Classical-VS-Follicular |
1.838670E-04 |
| Classical-VS-Other |
4.366200E-01 |
| Classical-VS-Normal |
2.564600E-03 |
| Tall-VS-Follicular |
2.712100E-02 |
| Tall-VS-Other |
4.870000E-01 |
| Tall-VS-Normal |
5.022300E-02 |
| Follicular-VS-Other |
5.822600E-01 |
| Follicular-VS-Normal |
9.25449999966688E-08 |
| Other-VS-Normal |
4.240200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.40999999967917E-07 |
| Normal-vs-N1 |
1.76799999995758E-06 |
| N0-vs-N1 |
1.624430E-01 |
|
|
